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A b s t r a c t: The occurrence of an isolated malignant peripheral nerve sheath 
tumor (MPNST) of the kidney capsule is extremely rare and its presence may only be ex-
pressed by an insidious onset of non-specific and misleading symptoms with a predomi-
nance of lower back pain. A computer tomography (CT) scan (as the imaging procedure 
of choice) will demonstrate the tumor location and its relation to the surrounding structu-
res. Tumor excision in toto is considered the treatment of choice, but it can be hazardous, 
especially if the tumor is adhering to the surrounding structures. Severe bleeding compli-
cations due to the damage of venous structures have to be considered, and establishing he-
mostasis may pose considerable difficulties. Therefore surgery should be attempted with 
full precautions and the patient must receive preoperative counseling. If malignancy can 
safely be excluded, a laparoscopic excision should be considered as an alternative treat-
ment as recurrence is unlikely. Definition of the originating nerve might not always be 
possible, and a minor degree of neurological impairment has therefore to be anticipated. 
A case of an isolated MPNST of the kidney capsule without neurofibromatosis 
is presented. The tumor was located in the fatty and fibrous capsule. It was surgically 
removed. The patient was further managed with radiotherapy and chemotherapy. An 
MPNST in such a location is very unusual. 
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Malignant peripheral nerve sheath tumor (MPNST) is a rare tumor deri-
ved from Schwann cells or pluripotent cells of the neural crest [1]. The World 
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Health Organization (WHO) coined the term MPNST replacing previous hete-
rogeneous and often confusing terms, such as malignant schwannoma, malign-
nant neurilemmoma, and neurofibrosarcoma for tumors of neurogenic origin 
and similar biological behavior [2]. It arises frequently in patients with neurofi-
bromatosis, type I (NF1) [3]. It most frequently affects patients who are bet-
ween 20 and 50 years old and represents 5-10% of soft-tissue sarcomas. Its lo-
cation in the retroperitoneum in a patient without neurofibromatosis is an exce-
edingly rare occurrence. Resection and combination chemotherapy are the ac-
cepted modes of treatment [4]. There are many histological variants, namely 






A 65-year-old female patient presented with dull, constant pain in her 
abdomen for the last 2 months. It was moderate in intensity and occurred to-
wards the left side of abdomen. It was associated with backache and nausea. 
There was also history of weight loss. On palpation, an abdominal mass of soft 
consistency was found left of the midline. Bowels were normal and there was 
nothing to suggest any episode of bowel or urinary tract obstruction. Her appe-
tite was good and she did not report any chronic systemic illness. On examina-
tion, the patient was elderly, weighing 60 kg, and of average build and nourish-
ment. She suffered insulin dependent diabetes mellitus (IDDM). Vital parame-
ters were normal and there was no icterus or pallor. The blood analysis showed 
a hemoglobin (Hb) level of 97 g/L, ESR 40 mm after the end of 1 hour, total 
leukocyte count 8.2 × 109/L and glycemia was 10.14 mmol/L. Total bilirubin, 
alkaline phosphatase, serum albumin, renal profile, serum urea and electrolytes 
were normal. Antibodies to hepatitis C virus (anti HCV) were negative. An ul-
trasound of the abdomen showed a mixed hiper and hypoechoic mass deep in 
the abdomen, located to the left of the spine, anterior to the psoas muscle in 
close contact with the left kidney. It was respiratory mobile. Areas of necrosis 
were seen. The mass was displacing the bowel loops without infiltrating them. 
However, the mass was infiltrating the retroperitoneal fat and renal capsule. A 
CT scan of the abdomen (Figure 1) revealed a large well-defined 20 × 20 cm mul-
tinodular and heterogeneous mass arising from the retroperitoneum and infiltra-
ting the left psoas as well as the left kidney capsule. It was not possible to 
distinguish whether its primary origin was from the kidney. It was not infiltra-
ting the surrounding gut. An intravenous pyelography was performed which sho-
wed a lateral dislocation of the left kidney with no invasion in renal calices, 
pelvis or ureter. Complete resection of the tumor was performed. The operation 
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went well with no major blood loss (Figure 2). Post-operative recovery was 
uneventful and the patient is doing well, pending further follow-up. She was put 
on palliative chemotherapy with alternating cycles of cyclophosphamide/doxo-
rubicin and cisplatin/etoposide. Six months after the operation the patient is still 
doing well; ultrasonography and a contrast-enhanced CT scan did not reveal any 
recurrence of the tumor (Figure 3). Histopathology of the resected mass revea-
led a left nephrectomy specimen with fibrous and fat kidney capsule weighing 
1820 g and measuring 20 × 15.5 ×11 cm (Figure 4). After removing the fat and 
fibrous capsule, a process easily performed, the kidney weighed 120 g, measu-
ring 13 × 4 × 6 cm with normal macroscopic morphology. However, the capsule 
contained a large tumor mass that encased the whole kidney but did not infil-
trate the kidney. On cut surface the tumor was gray-white with a sarcomatous 
(fish-flesh) (Figure 5) appearance with some necrotic areas. On routine hemato-
xyllin- eosin (HE) examination, the tumor was composed of monotonous tumor 
cells arranged in a storiform to whorled pattern focally with frequent mitotic 
figures. Areas of hyalinization were noted. Lymphocyte infiltration was present 
in multiple foci but the highest concentration of these cells was noted in the 
front of the tumor growth. Differential histochemical stainings (Reticulin stain; 
Van Gieson stain) revealed focal presence of collagen and abundant reticulin 
network. Immunohistochemistry was performed using antibodies for S-100 
protein (Figure 6), Vimentin (Figure 7), Actin (Figure 8), Desmin, CD31, CD34 
and Synaptophysin. Tumor cells were positive for S-100 protein, and Vimentin, 
there was focal positivity for Actin and there were no positive tumor cells 
stained for Desmin, Synaptophysin, CD31 and CD34. We reached a diagnosis 




Figure1 – CT scan of the abdomen revealed a large well-defined,lobulated  
and heterogeneous mass 
Слика 1 – Комpјуtеризирана tомоgрафија на абдомен со pриказ на gолема,  
добро оgраничена, лобулирана маса 
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Figure 2 – Intraoperative view 
Слика 2 – Инtраоpераtивен изgлед 
 
 
Figure 3 – CT scan control after 6 months did not reveal recurrence of the tumor 
Слика 3 – Конtролнаtа комpjуtеризирана tомоgрафија pо 6 месеци  
не pокажува рецидив на tумороt 
 
 
Figure 4 – Gross specimen 
Слика 4 – Макроскоpски изgлед 
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Figure 5 – Тumour was with sarcomatous (fish-flesh) appearance with some necrotic areas 




Figure 6 – S-100 protein × 200, positive staining of tumour cells 
Слика 6 – С-100 pроtеин × 200, pозиtивно pребојување на tуморски клеtки 
 
  
Figure 7 – Vimentin × 200, positive staining of tumour cells 
Слика 7 – Вименtин × 200, pозиtивно pребојување на tуморски клеtки 
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Figure 8 – Actin × 200, positive staining of tumour cells 





Malignant peripheral nerve sheath tumor is biologically an aggressive 
tumor for which the treatment of choice is surgery. A combination of gross, 
histopathological, immunohistochemical were all needed for diagnosis and 
grade of the MPNST [5]. Isolated neurogenic tumors, without any manifestation 
of neurofibromatosis, are reported rarely. Shahab et al. [6] described a case of 
neurofibroma of ileum without any manifestation of neurofibromatosis. Con-
trast enhanced CT and magnetic resonance imaging (MRI) are the most helpful 
imaging techniques to clearly identify tumor extent and to suggest its neuroge-
nic origin. The presence of heterogeneity with evidence of necrosis and hemor-
rhage on MRI, and increased uptake on positron emission tomography scan, 
may prove helpful in detecting malignant change. Malignant peripheral nerve 
sheath tumors should be approached by a multi disciplinary team, assuring the 
complete surgical removal of the lesion. Disease-free and overall survival sta-
tistics reinforce the aggressive nature of this unique soft tissue tumor [7]. Histo-
logical diagnosis is required, but diagnosis can be compromised by the hetero-
geneous nature of the tumor. Surgical treatment should be undertaken whenever 
possible. This type of sarcoma is often very aggressive with frequent develop-
ment of local recurrences and metastases [8]. Magnetic resonance imaging and 
CT scans are the first line procedures for localizing these tumors. Computer to-
mography scans can also be a guide for biopsies. A T1-weighted MR image re-
veals low-to-intermediate signal intensity, and T2-weighted MR images show 
high signal intensity in the lesion. Malignant peripheral nerve sheath tumors can 
arise within a previous radiation field. Malignant peripheral nerve sheath tumors 
tend to be larger (> 5 cm). They may exhibit ill-defined margins suggesting in-
filtration of adjacent tissues and associated edema. Heterogeneity with central 
necrosis on cross-sectional imaging is common in malignant lesions. Malignant 
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peripheral nerve sheath tumors generally involve the major nerve trunks and 
present with pain and neurologic symptoms, as well as a possible soft-tissue 
mass. Secondary MPNSTs can arise from prior radiation treatment, with a la-
tency period of longer than 10 years [9]. The treatment for MPNST has been 
combined modality that includes aggressive surgery with a wide margin of 
clearance or mass. Several cycles of adjuvant chemotherapy with cyclophospha-
mide/doxorubicin have been advocated [4]. However, Wanebo et al. [2] in their 





We suggest including MPNST of the kidney capsule in the differential 
diagnosis of abdominal masses. We also suggest, in a case of malignancy or 
large tumor, that an open surgical procedure should be applied. According to the 
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Pojavata na izoliran Malignant Peripheral Nerve Sheath Tumor (MPNST) 
na bubre`nata kapsula e izvonredno retka, a negovoto prisustvo se izra-
zuva so pojava na nespecifi~ni i nepovrzani simptomi so predominacija na 
bolka vo grbot. Kompjuteriziranata tomografija, kako imaging procedura 
na izbor ja demonstrira lokacijata na tumorot i negovata povrzanost so 
okolnite strukturi. Ekcizijata in toto na tumorot se smeta za procedura na 
izbor  koja }e ja poka`e lokacijata na tumorot i negoviot soodnos so 
okolnite strukturi. Trеba da se sovladaat te{kite komplikacii kako {to 
e krvaвeweto zaradi o{tetuvawe na okolnite strukturi. Vospostavuvaweto 
na hemostaza mo`e da pretstavuva seriozen problem. Zatoa, hirur{kata in-
tervencija treba de se izveduva so golema prеtpazlivost i dogovor so paci-
entot. Ako so sigurnost se isklu~i malignitetот, mo`e da se razmisluva i 
za laparoskopska ekcizija kako alternativen tretman. Definiraweto na 
nervot od koj poteknuva tumorot ne sekoga{ se identifikuva i zatoa mo`e 
da se o~ekuva pomal stepen na nevrolo{ka disfunkcija. 
 Prika`avme slu~aj na Malignant Peripheral Nerve Sheath Tumor (MPNST) 
na bubre`nata kapsula bez neurofibromatoza. Tumorot be{e lociran vo 
masnata i fibroznata kapsula. Istiot hirur{ki be{e otstranet. Podocna 
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pacientot be{e podlo`en na hemoterapija. MPNST so ovaa lokalizacija e 
ekstremno redok. 
 
Klu~ni zborovi: Malignant Peripheral Nerve Sheath Tumor (MPNST), кompjute-
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